Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move

statnews.com/2025/07/16/sarepta-therapeutics-layoffs-duchenne-muscular-dystrophy

Sarepta Therapeutics laid off more than one-third of its workforce, or approximately 500 employees, the company announced Wednesday — a drastic cost-cutting move following the deaths of two teenagers that forced the company to restrict usage of its gene therapy for Duchenne muscular…

This story appeared on statnews.com, 2025-07-17 02:11:32.989000.
The Entire Business World on a Single Page. Free to Use →